All chronical situations: 11 trials - AIM-HIGH - ARBITER 2 - ARBITER 6-HALTS (niacin vs ezetimibe) - Oxford Niaspan Study - HATS - CLAS - CLAS - Carlson (Stockholm) - CDP niacin - VA drugs - HPS 2-Thrive
All type of patients: 13 trials - AIM-HIGH - ARBITER 2 - ARBITER 6-HALTS (niacin vs ezetimibe) - Oxford Niaspan Study - Guyton - HATS - FATS - UCSF SCOR - CLAS - Carlson (Stockholm) - CDP niacin - VA drugs - HPS 2-Thrive
Patients with prior MI or with CHD: 3 trials - CLAS - CDP niacin - VA drugs